Chemotherapy of Borrmann type 4 gastric cancer
Suga, S.; Ina, K.; Horiuchi, Y.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(8): 2520-2525
1986
ISSN/ISBN: 0385-0684 PMID: 3017228 Document Number: 283136
In brief, the clinical course of patients with Borrmann type 4 gastric cancer is characterized by its marked tendency for peritoneal metastasis (P-factor). This paper dealt with the treatment of Borrmann type 4 gastric cancer from the viewpoint of the disease P-factor, and included the following topics; UFTM chemotherapy, pharmacokinetics of mitomycin C (i.v. vs i.p. use), case presentation, Port-A-catheter (implantable drug delivery system), suppression of collagen biosynthesis, prevention of the adverse effects of mitomycin C, neochemotherapy, and autopsy findings.
Document emailed within 1 workday
Related Documents
Izumi, T.; Kurihara, M.; Maruyama, T.; Sasaki, Y.; Shirakabe, H. 1984: Chemotherapy of unresectable Borrmann type 4 gastric cancer Gan no Rinsho. Japan Journal of Cancer Clinics 30(6 Suppl): 710-716Hirama, K.; Mikami, Y.; Nishi, T.; Suzuki, H.; Sugiyama, Y.; Konn, M. 1994: A case of gastric cancer with Borrmann type 4 responding to 5-FU-MMC combined chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(14): 2497-2499
Nomura, N.; Yamada, A.; Saitou, F.; Tsuzawa, T.; Yamashita, I.; Sakakibara, T.; Shimizu, T.; Sakamoto, T.; Karaki, Y.; Tazawa, K. 1994: Successful treatment of advanced gastric cancer (Borrmann 1 type) with FTP chemotherapy after reduction surgery Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(6): 865-868
Tominaga, J.; Izawa, M.; Yoshida, M.; Araki, N.; Kawase, S. 1991: A case of gastric cancer of Borrmann type IV complicated with carcinomatous peritonitis responding well to chemotherapy of tegafur only Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(12): 2159-2161
Iwase, H.; Morise, K.; Suga, S.; Ina, K.; Masuda, T.; Ohashi, M. 1987: Complete response of unresectable gastric cancer (Borrmann's type III) treated with combination chemotherapy of UFT and mitomycin--a case report Gan no Rinsho. Japan Journal of Cancer Clinics 33(6): 729-735
Akamo, Y.; Takeyama, H.; Mohri, N.; Teranishi, F.; Funahashi, H.; Manabe, T. 2000: An effective case of intraperitoneal and intra-arterial combined chemotherapy for unresectably advanced Borrmann type IV gastric carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(12): 2005-2007
Iwanaga, T. 1984: Treatment of macroscopical subtypes in Borrmann type 4 gastric carcinoma Gan no Rinsho. Japan Journal of Cancer Clinics 30(6 Suppl): 724-728
Kodera, Y.; Yamamura, Y.; Torii, A.; Uesaka, K.; Hirai, T.; Yasui, K.; Morimoto, T.; Kato, T.; Kito, T. 1996: Surgical treatment of Borrmann type IV gastric carcinoma: relevance of lymphadenectomy in improving survival Journal of the American College of Surgeons 183(5): 480-485
Tanemura, H.; Oshita, H.; Kanno, A.; Kusakabe, M.; Hatoh, T.; Yamada, M.; Adachi, T.; Nishio, K.; Saito, S.; Tomita, E.; Sugiyama, A.; Yamada, T. 2005: Neoadjuvant chemotherapy using TS-1 and CDDP against large type 3/Type 4/Bulky N 2 advanced gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(13): 2079-2085
Li, J.; Liu, Y.; Gao, J.; Guo, D. 2016: Value of CT perfusion imaging in differential diagnosis between Borrmann types II( and III( gastric cancer Zhonghua Wei Chang Wai Ke Za Zhi 19(10): 1149-1153
Ohnuma, S.; Kitamura, M.; Arai, K.; Iwasaki, Y.; Takenami, K.; Ueno, T. 1999: A case of type 4 gastric cancer with peritoneal dissemination treated with intra-aortic chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(7): 975-978
Sato, Y.; Ishii, H.; Terada, T.; Amaya, S.; Koizumi, H.; Fujisawa, K.; Munemoto, Y.; Mitsui, T.; Iida, Y.; Miura, S. 2010: A case of AFP-producing gastric cancer with hepatic metastases that accompanied early gastric cancer treated effectively by chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(10): 1957-1960
Căinap, C.; Părău, A.; Muntean, A.; Hodorog, A.; Vlad, L. 2010: New generation chemotherapy in the treatment of operated gastric cancer--an alternative to traditional chemotherapy Chirurgia 105(1): 31-36
Sato, A.; Yamamoto, W.; Takebuchi, K.; Hiratsuka, N.; Tadokoro, K.; Ushio, J. 2001: Home chemotherapy and/or outpatient chemotherapy for patient with advanced gastric cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 4): 616-620
Inokuchi, M.; Yamashita, T.; Yamada, H.; Kojima, K.; Sekita, Y.; Kawano, T.; Sugihara, K. 2007: Second-line chemotherapy in gastric cancer following S-1 with CPT-11 chemotherapy performed as clinical trial Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(6): 875-879
Kato, M.; Kinoshita, K.; Sawa, T.; Yoshimitsu, S.; Tomita, F.; Takano, Y.; Segawa, M.; Ohyama, S.; Yonemura, Y.; Miwa, K. 1990: Neoadjuvant chemotherapy of far advanced gastric cancer--effect of preoperative chemotherapy by PMUE (CDDP, MMC, UFT, etoposide Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(3 Part 1): 391-396
Uji, K.; Tamura, S.; Takeno, A.; Miki, H.; Kanemura, T.; Yanai, A.; Kobayashi, M.; Yoshioka, Y.; Teramoto, A.; Nakahira, S.; Suzuki, R.; Nakata, K.; Egawa, C.; Okamura, S.; Sugimoto, K.; Takatsuka, Y. 2011: A case of gastric cancer with liver metastasis had a good reaction to S-1/CDDP chemotherapy after S-1 chemotherapy was ineffective Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(10): 1691-1694
Akamo, Y.; Mizuno, I.; Takeyama, H.; Mohri, N.; Ueda, T.; Shibata, T.; Yotsuyanagi, T.; Manabe, T. 1997: Chemotherapy targeting regional lymph nodes by gastric submucosal injection of liposomal adriamycin in patients with gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(12): 1712-1714
Ishikawa, T.; Nomura, K.; Baba, Y.; Hayashi, S.-i.; Oota, H.; Yoshida, T.; Kamimura, T. 2003: A case of advanced gastric cancer with liver and intra-abdominal lymph node metastasis treated by hypertensive selective chemotherapy with pharmacokinetic modulating chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(8): 1151-1155
Gerstein, E.S.; Shcherbakov, A.M.; Kaz'min, A.I.; Ognerubov, N.A.; Kushlinskiĭ, N.E. 2003: Urokinase and tissue type plasminogen activators and their type-1 inhibitor (PAI-1) in gastric cancer Voprosy Onkologii 49(2): 165-169